Quick Contact

    News and Events

    2022/05/12

    BGI’s 2019-nCoV Ag Test (Latex Chromatography Assay) Is Included in the Australian Register of Therapeutic Goods

    BGI announces that its 2019-nCoV Ag Test (Latex Chromatography Assay) has recently been included in the Australian Register of Therapeutic Goods (ARTG). Therapeutic goods entered in the ARTG can be lawfully supplied in Australia.

    The test kit is designed for detecting SARS CoV-2 nucleocapsid protein antigen for individuals suspected to have contracted COVID-19. The test is available at the point of care for trained health professionals (nasopharyngeal swabs), and for self-testing by laypersons (nasal swabs).

    The test solution can assist in diagnosing symptomatic individuals within the first seven days of symptom onset. Self-testing can be easily conducted at home, at schools, at work, etc. It will provide reliable and quick results in 15-30 minutes.

    Follow us
    微信二维码

    Don’t hesitate to contact us to request a quote or to talk more about your requirements and how we can support your needs.